scholarly journals A Case of Intramural Duodenal Hematoma Accompanied by Acute Pancreatitis Following Endoscopic Hemostasis for Duodenal Ulcer Bleeding

2009 ◽  
Vol 53 (5) ◽  
pp. 311 ◽  
Author(s):  
Min Keun Song ◽  
Joon Beom Shin ◽  
Ha Na Park ◽  
Eun Jin Kim ◽  
Ki Cheun Jeong ◽  
...  
Keyword(s):  
Duodenal Ulcer ◽  
Acute Pancreatitis ◽  
Endoscopic Hemostasis ◽  
Ulcer Bleeding ◽  
Duodenal Hematoma

scholarly journals A Rare Case of Pancreas Divisum Accompanied by Acute Pancreatitis Following Endoscopic Hemostasis for Duodenal Ulcer Bleeding

2017 ◽  
Vol 69 (4) ◽  
pp. 248 ◽  
Author(s):  
Yong Hyeok Choi ◽  
Soon Man Yoon ◽  
Eun Bee Kim ◽  
Youngmin Oh ◽  
Keunmo Kim ◽  
...  
Keyword(s):  
Duodenal Ulcer ◽  
Acute Pancreatitis ◽  
Rare Case ◽  
Pancreas Divisum ◽  
Endoscopic Hemostasis ◽  
Ulcer Bleeding ◽  
Pancréas Divisum

scholarly journals Fatal acute pancreatitis following sclerosis of a bleeding duodenal ulcer complicated by an intramural duodenal hematoma

2012 ◽  
Vol 104 (11) ◽  
pp. 603-604 ◽  
Author(s):  
João Dinis Silva ◽  
Nuno Veloso ◽  
Rogério Godinho ◽  
Lurdes Gonçalves ◽  
Isabel Medeiros ◽  
...  
Keyword(s):  
Duodenal Ulcer ◽  
Acute Pancreatitis ◽  
Duodenal Hematoma ◽  
Bleeding Duodenal Ulcer

EFFICACY OF INITIAL AND PERMANENT HEMOSTASIS OF THE ENDOSCOPIC HEMOCLIP METHOD COMBINED WITH HIGH-DOSE INFUSION OF PROTON PUMP INHIBITOR IN PATIENTS WITH PEPTIC ULER BLEEDING

2018 ◽  
pp. 15-21
Author(s):  
Hieu Tam Huynh ◽  
Dang Quy Dung Ho
Keyword(s):  
Peptic Ulcer ◽  
Success Rate ◽  
Endoscopic Hemostasis ◽  
Ulcer Bleeding ◽  
Injection Sclerotherapy ◽  
High Dose ◽  
Peptic Ulcers ◽  
Peptic Ulcer Bleeding ◽  
Bleeding Peptic Ulcers ◽  
Hemostatic Therapy

Background: Peptic ulcer bleeding is one of the common medical emergencies. The hemostatic efficacy of endoscopic therapeutic modalities has been reported in many studies and frequently has been found to exceed 90%. Four groups of modalities are used in the endoscopic management of bleeding peptic ulcers: thermal probe methods, injection sclerotherapy, local spray methods, and mechanical hemostatic therapy. The endoscopic hemoclip method is a safe and effective hemostatic therapy for managing bleeding peptic ulcers. Objective: To determine the success rate of hemoclip in endoscopic hemostasis. Patients and methods: Clinical intervention study on 36 patients with peptic ulcer bleeding admitted in Can Tho Central General Hospital from May 2012 to November 2014. All the patients underwent emergency endoscopy for hemostasis by hemoclip and high-dose PPI use. Results: The success rate of initial hemostasis was 97.2%, and permanent hemostasis was 91.7%. The rates of rebleeding, surgery, mortality were 11.1%, 5.6%, 2.8%, respectively. Conclusion: Endoscopic hemostasis therapy by clipping combined with high- dose PPI is an effective, relatively safe treatment for peptic ulcer bleeding. Key words: Peptic ulcer bleeding, hemoclip, endoscopic hemostasis therapy

scholarly journals Tsutsugamushi Disease Complicated with Duodenal Ulcer Bleeding

2008 ◽  
Vol 97 (8) ◽  
pp. 1873-1875
Author(s):  
Shuya Yoshinaga ◽  
Shunpei Hashigo ◽  
Katsuya Nagaoka ◽  
Susumu Hijioka ◽  
Yoshi Takekuma ◽  
...  
Keyword(s):  
Duodenal Ulcer ◽  
Ulcer Bleeding ◽  
Tsutsugamushi Disease

scholarly journals A Rare Cause of Acute Pancreatitis: Intramural Duodenal Hematoma

2012 ◽  
Vol 2012 ◽  
pp. 1-3 ◽  
Author(s):  
Hemant Goyal ◽  
Umesh Singla ◽  
Roli R. Agrawal
Keyword(s):  
Acute Pancreatitis ◽  
Emergency Room ◽  
Outlet Obstruction ◽  
Interesting Case ◽  
Pancreatic Enzymes ◽  
Initial Evaluation ◽  
Healthy Male ◽  
Imaging Studies ◽  
Acute Gastritis ◽  
Duodenal Hematoma

We describe an interesting case of intramural duodenal hematoma in an otherwise healthy male who presented to emergency room with gradually progressive abdominal pain, nausea, and vomiting. This condition was missed on initial evaluation and patient was discharged from emergency room with diagnosis of acute gastritis. After 3 days, patient came back to emergency room and abdominal imaging studies were conducted which showed that patient had intramural duodenal hematoma associated with gastric outlet obstruction and pancreatitis. Hematoma was the cause of acute pancreatitis as pancreatic enzymes levels were normal at the time of first presentation, but later as the hematoma grew in size, it caused compression of pancreas and subsequent elevation of pancreatic enzymes. We experienced a case of pancreatitis which was caused by intramural duodenal hematoma. This case was missed on initial evaluation. We suggest that physicians should be more vigilant about this condition.

Prevention of recurrent idiopathic gastroduodenal ulcer bleeding: a double-blind, randomised trial

Gut ◽  
2019 ◽  
Vol 69 (4) ◽  
pp. 652-657 ◽  
Author(s):  
Grace L H Wong ◽  
Louis H S Lau ◽  
Jessica Y L Ching ◽  
Yee-Kit Tse ◽  
Rachel H Y Ling ◽  
...  
Keyword(s):  
Duodenal Ulcer ◽  
Randomised Trial ◽  
Ulcer Bleeding ◽  
Recurrent Ulcer ◽  
Gi Bleeding ◽  
Double Blind ◽  
Upper Gi Bleeding ◽  
Upper Gi ◽  
History Of ◽  
Bleeding Ulcers

ObjectivePatients with a history of Helicobacter pylori-negative idiopathic bleeding ulcers have a considerable risk of recurrent ulcer complications. We hypothesised that a proton pump inhibitor (lansoprazole) is superior to a histamine 2 receptor antagonist (famotidine) for the prevention of recurrent ulcer bleeding in such patients.DesignIn this industry-independent, double-blind, randomised trial, we recruited patients with a history of idiopathic bleeding ulcers. After ulcer healing, we randomly assigned (1:1) patients to receive oral lansoprazole 30 mg or famotidine 40 mg daily for 24 months. The primary endpoint was recurrent upper GI bleeding within 24 months, analysed in the intention-to-treat population as determined by an independent adjudication committee.ResultsBetween 2010 and 2018, we enrolled 228 patients (114 patients in each study group). Recurrent upper GI bleeding occurred in one patient receiving lansoprazole (duodenal ulcer) and three receiving famotidine (two gastric ulcers and one duodenal ulcer). The cumulative incidence of recurrent upper GI bleeding in 24 months was 0.88% (95% CI 0.08% to 4.37%) in the lansoprazole arm and 2.63% (95% CI 0.71% to 6.91%) in the famotidine arm (p=0.313; crude HR 0.33, 95% CI 0.03 to 3.16, p=0.336). None of the patients who rebled used aspirin, non-steroidal anti-inflammatory drugs or other antithrombotic drugs.ConclusionThis 2-year, double-blind randomised trial showed that among patients with a history of H. pylori-negative idiopathic ulcer bleeding, recurrent bleeding rates were comparable between users of lansoprazole and famotidine, although a small difference in efficacy cannot be excluded.Trial registration numberNCT01180179; Results.

Sign in / Sign up

Export Citation Format

Share Document